HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xiaomin Wang Selected Research

Radiotherapy

1/2023Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
1/2023High-Dose Versus Standard-Dose Intensity-Modulated Radiotherapy With Concurrent Paclitaxel Plus Carboplatin for Patients With Thoracic Esophageal Squamous Cell Carcinoma: A Randomized, Multicenter, Open-Label, Phase 3 Superiority Trial.
1/2022Significant response of pulmonary sarcomatoid carcinoma with obstructive atelectasis to treatment with the PD-1 inhibitor camrelizumab combined with transbronchial cryoablation: A case report and literature review.
6/2021Age plays an important role in the decision of definitive concurrent chemoradiotherapy (CCRT) for esophageal squamous cell carcinoma (ESCC): a propensity-score matched analysis of multicenter data (3JECROG R-02A).
9/2020A multicenter prospective phase III clinical randomized study of simultaneous integrated boost intensity-modulated radiotherapy with or without concurrent chemotherapy in patients with esophageal cancer: 3JECROG P-02 study protocol.
9/2020Impact of homogeneous and heterogeneous risk factors on the incidence and prognosis of brain metastases in patients with hepatocellular carcinoma.
9/2020Dose escalation of 3D radiotherapy is effective for esophageal squamous cell carcinoma: a multicenter retrospective analysis (3JECROG R-03).
1/2020Stage III Esophageal Squamous Cell Carcinoma Patients With Three-Dimensional Conformal or Intensity-Modulated Radiotherapy: A Multicenter Retrospective Study.
4/2019A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
1/2019Correction to: A multicenter phase III study comparing Simultaneous Integrated Boost (SIB) radiotherapy concurrent and consolidated with S-1 versus SIB alone in elderly patients with esophageal and esophagogastric cancer - the 3JECROG P-01 study protocol.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xiaomin Wang Research Topics

Disease

102Neoplasms (Cancer)
05/2024 - 03/2004
31Parkinson Disease (Parkinson's Disease)
05/2024 - 06/2004
28Inflammation (Inflammations)
05/2024 - 01/2008
24Hepatocellular Carcinoma (Hepatoma)
01/2024 - 10/2008
19Neoplasm Metastasis (Metastasis)
12/2023 - 10/2008
17Alzheimer Disease (Alzheimer's Disease)
12/2023 - 01/2010
14Breast Neoplasms (Breast Cancer)
03/2024 - 01/2011
13Hypoxia (Hypoxemia)
11/2023 - 04/2007
11Infections
01/2021 - 11/2006
11Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 05/2004
10COVID-19
11/2023 - 12/2020
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 05/2015
8Multiple Myeloma
10/2023 - 02/2015
8Neuroinflammatory Diseases
09/2023 - 11/2008
8Lung Neoplasms (Lung Cancer)
01/2022 - 03/2006
7Hemorrhage
04/2024 - 02/2016
7Leukemia
03/2024 - 02/2003
7Cognitive Dysfunction
12/2023 - 08/2015
7Esophageal Squamous Cell Carcinoma
01/2023 - 01/2020
7Carcinoma (Carcinomatosis)
01/2022 - 03/2006
6Pulmonary Edema
11/2023 - 07/2021
6Lung Injury
07/2023 - 01/2021
6Ischemia
01/2023 - 01/2012
5Esophageal Neoplasms (Esophageal Cancer)
01/2023 - 01/2012
5Melanoma (Melanoma, Malignant)
09/2019 - 08/2010
4Fatigue
05/2024 - 11/2017
4Squamous Cell Carcinoma of Head and Neck
05/2024 - 07/2018
4Hematologic Neoplasms (Hematological Malignancy)
03/2024 - 07/2010
4Dementia (Dementias)
11/2023 - 01/2018
4Adenocarcinoma of Lung
11/2023 - 01/2020
4Pain (Aches)
10/2023 - 01/2016
4Heart Diseases (Heart Disease)
09/2023 - 03/2009
4Chronic Obstructive Pulmonary Disease (COPD)
09/2023 - 07/2020
4Respiratory Tract Diseases (Respiratory Tract Disease)
05/2023 - 11/2020
4Carcinogenesis
01/2023 - 08/2013
4Stroke (Strokes)
01/2020 - 02/2012
4Lymphoma (Lymphomas)
10/2018 - 03/2004
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
04/2024 - 08/2021
3Fibrosis (Cirrhosis)
03/2024 - 01/2021
3Huntington Disease (Huntington's Disease)
12/2023 - 01/2019
3Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
10/2023 - 01/2014
3Lung Diseases (Lung Disease)
07/2023 - 10/2007

Drug/Important Bio-Agent (IBA)

43Proteins (Proteins, Gene)FDA Link
05/2024 - 04/2007
17Biomarkers (Surrogate Marker)IBA
12/2023 - 10/2007
12CytokinesIBA
11/2023 - 02/2003
12Therapeutic UsesIBA
01/2023 - 02/2012
10Amyloid (Amyloid Fibrils)IBA
10/2021 - 01/2010
10Peptides (Polypeptides)IBA
01/2020 - 03/2004
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
10/2023 - 04/2007
7RNA (Ribonucleic Acid)IBA
03/2024 - 05/2015
7pomalidomideIBA
10/2021 - 02/2015
7Messenger RNA (mRNA)IBA
01/2021 - 01/2003
7MicroRNAs (MicroRNA)IBA
10/2019 - 03/2013
6InflammasomesIBA
11/2023 - 12/2017
6Particulate MatterIBA
07/2023 - 02/2013
6DNA (Deoxyribonucleic Acid)IBA
08/2021 - 01/2012
6SynucleinsIBA
12/2017 - 06/2011
5Neuroprotective AgentsIBA
09/2023 - 04/2010
5Long Noncoding RNAIBA
11/2022 - 11/2016
5fucoidanIBA
08/2018 - 09/2009
5Small Interfering RNA (siRNA)IBA
04/2018 - 03/2009
4Sirolimus (Rapamycin)FDA Link
03/2024 - 11/2013
4MelatoninIBA
12/2023 - 01/2017
4Immune Checkpoint InhibitorsIBA
11/2023 - 01/2022
4Dexamethasone (Maxidex)FDA LinkGeneric
10/2023 - 02/2016
41- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
09/2023 - 09/2009
4tenuigeninIBA
09/2023 - 06/2011
4FlavonoidsIBA
10/2022 - 07/2016
4astragaloside AIBA
02/2022 - 01/2018
4Antiviral Agents (Antivirals)IBA
08/2020 - 10/2010
4Lenalidomide (CC 5013)FDA Link
01/2020 - 07/2010
4Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 01/2018
4LipidsIBA
01/2019 - 06/2011
4Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
08/2015 - 02/2008
4triptolideIBA
03/2015 - 11/2008
4Prealbumin (Transthyretin)IBA
02/2011 - 10/2007
3isocitric acid (isocitrate)IBA
04/2024 - 01/2022
3enasidenibIBA
04/2024 - 01/2022
3Mutant Proteins (Protein, Mutant)IBA
04/2024 - 01/2022
3Mechanistic Target of Rapamycin Complex 1IBA
03/2024 - 11/2013
3COVID-19 VaccinesIBA
11/2023 - 09/2022
3VaccinesIBA
11/2023 - 01/2021
3Gefitinib (Iressa)FDA Link
11/2023 - 02/2008
3Oxygen (Dioxygen)IBA
09/2023 - 01/2008
3EnzymesIBA
07/2023 - 01/2019
3Circular RNAIBA
07/2023 - 01/2021
3Histones (Histone)IBA
06/2023 - 01/2019
3Paclitaxel (Taxol)FDA LinkGeneric
01/2023 - 01/2018
3Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2023 - 01/2020

Therapy/Procedure

49Therapeutics
03/2024 - 09/2003
17Drug Therapy (Chemotherapy)
12/2023 - 01/2014
11Radiotherapy
01/2023 - 01/2019
7Chinese Traditional Medicine (Traditional Chinese Medicine)
03/2024 - 01/2014
6Chemoradiotherapy
01/2023 - 01/2020
5Immunotherapy
12/2022 - 01/2021
5Transplantation
11/2021 - 06/2004
5Electroacupuncture
06/2018 - 06/2013
4Lasers (Laser)
02/2011 - 10/2007
3Activities of Daily Living (ADL)
05/2024 - 12/2018
3Aftercare (After-Treatment)
03/2024 - 02/2012